Aquestive Therapeutics (AQST) Earnings Date, Estimates & Call Transcripts $2.85 +0.03 (+1.06%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aquestive Therapeutics Earnings Summary Upcoming Earnings DateMay. 6After Market ClosesEstimatedConsensus EPS (Mar. 5) -$0.14 Actual EPS (Mar. 5) -$0.19 Missed By -$0.05 Actual Revenue (Mar. 5) $11.87MAquestive Therapeutics issued Q4 2024 earnings on March 5, 2025, reporting an EPS of -$0.19, which missed analysts' consensus estimates of -$0.14 by $0.05. Quarterly revenue was reported to be $11.87 million, below analysts' expectations of $13.11 million. With a trailing EPS of -$0.52, Aquestive Therapeutics' earnings are expected to decrease next year, from ($0.46) to ($0.56) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K) Slide DeckAQST Upcoming EarningsAquestive Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Slide DeckFull Screen Slide DeckPowered by Get Aquestive Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aquestive Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAQST Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AQST Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Aquestive Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.17-$0.17-$0.17Q2 20251-$0.15-$0.15-$0.15Q3 20251-$0.14-$0.14-$0.14Q4 20251-$0.15-$0.15-$0.15FY 20254-$0.61-$0.61-$0.61Q1 20261-$0.15-$0.15-$0.15Q2 20261-$0.16-$0.16-$0.16Q3 20261-$0.15-$0.15-$0.15Q4 20261-$0.11-$0.11-$0.11FY 20264($0.57)($0.57)($0.57) Aquestive Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------3/5/2025Q4 2024-$0.14-$0.19 -$0.05-$0.19$13.11M$11.87M11/4/2024Q3 2024-$0.12-$0.13 -$0.01-$0.13$12.69M$13.54M8/6/2024Q2 2024-$0.11-$0.03+$0.08-$0.03$12.62M$20.10M5/13/2024Q1 2024-$0.09-$0.17 -$0.08-$0.17$12.22M$12.05M3/5/2024Q4 2023-$0.08-$0.12 -$0.04-$0.12$11.79M$13.21M11/6/2023Q3 2023-$0.11-$0.03+$0.08-$0.03$11.33M$13.00M8/7/2023Q2 2023-$0.11-$0.10+$0.01-$0.10$10.76M$13.24M5/2/2023Q1 2023-$0.10$0.11+$0.21$0.11$10.17M$11.13M Aquestive Therapeutics Earnings - Frequently Asked Questions When is Aquestive Therapeutics's earnings date? Aquestive Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on AQST's earnings history. What guidance has Aquestive Therapeutics issued on next quarter's earnings? Aquestive Therapeutics updated its FY 2025 earnings guidance on Wednesday, March, 5th. The company issued revenue guidance of $47.0 million-$56.0 million, compared to the consensus revenue estimate of $53.0 million. Did Aquestive Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aquestive Therapeutics (NASDAQ:AQST) missed the analysts' consensus estimate of ($0.14) by $0.05 with a reported earnings per share (EPS) of ($0.19). Learn more on analysts' earnings estimate vs. AQST's actual earnings. How can I listen to Aquestive Therapeutics's earnings conference call? The conference call for Aquestive Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Aquestive Therapeutics's conference call transcript? The conference call transcript for Aquestive Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Aquestive Therapeutics generate each year? Aquestive Therapeutics (NASDAQ:AQST) has a recorded annual revenue of $57.56 million. How much profit does Aquestive Therapeutics generate each year? Aquestive Therapeutics (NASDAQ:AQST) has a recorded net income of -$7.87 million. AQST has generated -$0.52 earnings per share over the last four quarters. What is Aquestive Therapeutics's EPS forecast for next year? Aquestive Therapeutics's earnings are expected to decrease from ($0.46) per share to ($0.56) per share in the next year. More Earnings Resources from MarketBeat Related Companies Adaptive Biotechnologies Earnings Date Iovance Biotherapeutics Earnings Date Wave Life Sciences Earnings Date 89bio Earnings Date Collegium Pharmaceutical Earnings Date Mineralys Therapeutics Earnings Date Intellia Therapeutics Earnings Date Spyre Therapeutics Earnings Date Zymeworks Earnings Date Arcus Biosciences Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? This page (NASDAQ:AQST) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aquestive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AQST Stock Free AQST Stock Alerts